期刊文献+

2型糖尿病不同尿白蛋白排泄率患者血清中miR-342-5p、miR-423-5p的表达量及临床意义 被引量:5

Serum expression and clinical significance of miR-342-5p and miR-423-5p in type 2 diabetes mellitus patients with different urinary albumin excretion rate
下载PDF
导出
摘要 目的:研究2型糖尿病不同尿白蛋白排泄率患者血清中miR-342-5p、miR-423-5p的表达量及临床意义。方法:选择2013年5月~2015年12月在我院接受治疗的126例2型糖尿病患者,并根据尿白蛋白/肌酐比值(ACR)分为正常尿蛋白组(NA组)、微量尿蛋白组(MI组)、大量尿蛋白组(MA)组;另取50例健康志愿者作为对照组。采集血清并检测miR-342-5p、miR-423-5p的表达量以及p38MAPK、TGF-β1信号通路分子的含量。结果:NA组、MI组、MA组血清中miR-342-5p和miR-423-5p的表达量均显著高于对照组且ACR越高、血清中miR-342-5p和miR-423-5p的表达量越高;miR-342-5p和miR-423-5p高表达患者血清中MAPKKK、p38MAPK、CREB、ATF-2、转化生长因子β1(TGF-β1)、Smad2、Smad3、Smad4、CTGF的含量显著高于miR-342-5p和miR-423-5p低表达患者。结论:2型糖尿病患者体内高表达的miR-342-5p和miR-423-5p能够通过靶向调节p38MAPK、TGF-β1信号通路的方式来造成糖尿病肾病的发生。 Objective: To study the serum expression and clinical significance of miR-342-5p and miR-423-5p in type 2 diabetes mellitus patients with different urinary albumin excretion rate. Methods: A total of 126 patients with type 2 diabetes mellitus treated in our hospital between May 2013 and December 2015 were selected and divided into normal urine protein group( NA group),micro-urine protein group( MI group) and macro-urine protein group( MA group) according to the urinary albumin / creatinine ratio( ACR); 50 healthy volunteers were selected as control group. Serum was collected to determine the expression miR-342-5p and miR-423-5p as well as the content of p38 MAPK and TGF-β1 signaling pathway molecules. Results: Serum miR-342-5p and miR-423-5p expression of NA group,MI group and MA group were significantly higher than those of control group and the higher the ACR,the higher the serum miR-342-5p and miR-423-5p expression; serum MAPKKK,p38 MAPK,CREB,ATF-2,TGF-β1,Smad2,Smad3,Smad4 and CTGF content of patients with high miR-342-5p and miR-423-5p expression were significantly higher than those of patients with low miR-342-5p and miR-423-5p expression. Conclusions: Highly expressed miR-342-5p and miR-423-5p in patients with type2 diabetes mellitus can be targeted to adjust p38 MAPK and TGF-β1 signaling pathway to cause the occurrence of diabetic nephropathy.
作者 孙晓兰 陈敏
出处 《海南医学院学报》 CAS 2017年第1期62-65,共4页 Journal of Hainan Medical University
基金 上海市卫生局科研课题计划项目(20130112)~~
关键词 糖尿病肾病 微小RNA P38MAPK 转化生长因子Β1 Diabetic nephropathy microRNA p38MAPK Transforming growth factor-β1
  • 相关文献

参考文献1

二级参考文献11

  • 1Ortega FJ, Mercader JM, Moreno-Navarrete JM, et al. Profiling of cir- culating microRNAs reveals common microRNAs linked to type 2 dia- betes that change with insulin sensitization [ J]. Diabetes Care,2014, 37(5) :1375-1383.
  • 2Me Callie B, Schoolcraft WB, Katz-Jaffe MG. Aberration of blastocyst microRNA expression is associated with human infertility [ J ]. Fertil Steril,2010 ,93 (7) :2374-2382.
  • 3Zhang C, Li K, Shi B,et al. Detection of serum beta (2)-GP I -Lp (a) complexes in patients with systemic lupus erythematosus [ J ]. Clin Chim Acta,2010,411 (5-6) :395-399.
  • 4Wang JJ, Zhang CN, Gong JB, et al. Development of new enzyme- linked immunosorbent assay for oxidized lipoprotein (a) by using pu- rified human oxidized lipoprotein (a) autoantibodies as capture anti- body[ J]. Clin Chlm Acta ,2007,385 ( 1-2 ) :73-78.
  • 5Rome S. Are extracellular microRNAs involved in type 2 diabetes and related pathologies? [J]. Clin Biochem,2013,46( 10-11 ) :937-945.
  • 6Wei Y, Nazari-Jahantigh M, Chan L, et al. The microRNA-342-5 p fos- ters inflmmatory macrophage activation through an Aktl-and microR- NA-155-dependent pathway during atherosclerosis [ J ]. Circulation, 2013,127 ( 15 ) : 1609-1619.
  • 7Ge Y, Zhao K, Qi Y, et al. Serum microRNA expression profile as a bi- omarker for the diagnosis of pertussis [ J ]. Mol Biol Rep, 2013,40 (2) :1325-1332.
  • 8Wang C, Niu DM, Hu J, et al. Elevated serum β2-glycoprotein-1 -lipo- protein( a ) complexes levels are associated with the presence and complications in type 2 diabetes mellitus [ J ]. Diabetes Res Clin Pract, 2013,100(2) :250-256.
  • 9Prats-Puig A, Ortega FJ, Mercader JM, et al. Changes in circulating microRNAs are associated with childhood obesity [ J ]. J Clin Endocri- nol Metab ,2013,98(10) :E1655-E1660.
  • 10Ortega FJ, MercaderJM, Catalan V, et al. Targeting the circulating microRNA signature of obesity [ J ]. Clin Chem, 2013,59 ( 5 ) : 781- 792.

共引文献14

同被引文献55

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部